Table of Contents
ISRN Nanotechnology
Volume 2012, Article ID 407429, 9 pages
Review Article

Chemotherapy of Prostate Cancer by Targeted Nanoparticles Trackable by Magnetic Resonance Imaging

1Department of Chemistry, Tuskegee University, Tuskegee, AL 36088, USA
2Department of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA

Received 28 March 2012; Accepted 28 May 2012

Academic Editors: R. B. Azevedo, M. Fernández-García, and K. H. Park

Copyright © 2012 Mohamed O. Abdalla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Prostate cancer (CaP) is the commonest diagnosed malignancy and the second main cause of cancer mortality in males in the United States. Thus, there is an urgent need to develop novel drug delivery systems to improve the chemotherapy option for CaP patients. The goal of this paper is to describe novel moleculary guided nanoscale drug delivery system with dual functionality for treatment and MR imaging of CaP. We describe the synthesis of iron oxide nanoparticles (IONPs) which are then coated with carboxyl-ended amphiphilic polymer. We present the protocol for tethering of the CaP targeting protein, human amino terminal fragment (hATF) to the terminal carboxyls of the IONPs. We describe the drug loading and release and the methods for measuring of the internalization of the hATF-guided IONPs into CaP cells. We also describe the methods for usages of IONPs are MR imaging contrast agent and successful targeted drug carriers.